PTC Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €1.28B +18.3% €181.51M +70.3% 14.2% +0.043 pp €439.27M +41.5% 34.4% +0.056 pp
    (estimated) €1.08B +19.3% €106.58M -281.3% 9.9% +0.16 pp €310.47M -885.3% 28.8% +0.33 pp
    (estimated) €904.02M +25.4% -€58.78M -67.4% -6.5% +0.19 pp -€39.53M -10.7% -4.4% +0.018 pp
    (estimated) €720.91M -51.3% -€180.34M -133.5% -25.0% -0.61 pp -€44.25M -107.0% -6.1% -0.49 pp
    (estimated) €1.48B +115.0% €538.99M -273.9% 36.4% +0.81 pp €629.31M -829.2% 42.5% +0.55 pp
    €688.14M -14.0% -€309.87M -42.0% -45.0% +0.22 pp -€86.31M +167.7% -12.5% -0.085 pp
    €799.92M +34.2% -€534.46M +12.1% -66.8% +0.13 pp -€32.24M -81.5% -4.0% +0.25 pp
    €596.04M +29.7% -€476.81M +6.7% -80.0% +0.17 pp -€174.17M +23.0% -29.2% +0.016 pp
    €459.39M +41.4% -€446.86M +19.6% -97.3% +0.18 pp -€141.59M +20.2% -30.8% +0.054 pp
    €324.77M +24.0% -€373.73M +74.2% -115.1% -0.33 pp -€117.79M +159.6% -36.3% -0.19 pp
    €261.84M +16.0% -€214.58M +96.4% -82.0% -0.34 pp -€45.38M +339.3% -17.3% -0.13 pp
    €225.81M +36.2% -€109.25M +62.1% -48.4% -0.077 pp -€10.33M +74.0% -4.6% -0.0099 pp
    €165.81M +135.0% -€67.38M -44.4% -40.6% +1.3 pp -€5.94M -93.2% -3.6% +1.2 pp
    €70.54M +124.9% -€121.21M -16.6% -171.8% +2.9 pp -€86.82M -16.3% -123.1% +2.1 pp
    €31.36M +60.1% -€145.38M +81.8% -463.6% -0.55 pp -€103.73M +131.2% -330.8% -1.0 pp
    €19.59M -26.7% -€79.97M +81.8% -408.3% -2.4 pp -€44.87M +14.2% -229.1% -0.82 pp
    €26.72M +8.9% -€43.99M +96.6% -164.6% -0.73 pp -€39.30M -3.5% -147.1% +0.19 pp
    €24.55M -70.9% -€22.38M -184.9% -91.2% -1.2 pp -€40.72M +131.7% -165.9% -1.5 pp
    €84.41M €26.36M 31.2% -€17.57M -20.8%

    Notifications